PFIZER has paid $US784 million
to settle claims about its Wyeth
Pharmaceuticals unit overcharging
the US Medicaid scheme.
It was alleged the unit was
failing to offer the public the same
rebates for the drug pantoprazole
(for treating oesophagitis) as were
being offered to private hospitals
between 2001 and 2006.
A coalition of 15 U.S. states filed
a complaint in a federal court in
Massachusetts in 2009.
Pfizer has reissued its results for
the fourth quarter & the full year.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Mar 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.